Cite

HARVARD Citation

    Ference, B. et al. (2018). LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis. Atherosclerosis. p. . [Online]. 
  
Back to record